FACE Phase II (a Stage II Trial)
NCT07130669
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
How to ensure adherence to computerized cognitive training in unsupervised circumstances (e.g., at-home, self-administered) in older adults at risk for Alzheimer's disease (AD) or AD related dementia (AD/ADRD) is understudied. The objective of the R33 study is to test a novel facial expression-based personalization engine (FPE) for monitoring and modulating real-time effective engagement, with an ultimate goal of enhancing long-term adherence in unsupervised cognitive training in older adults at risk for AD/ADRD.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- MCI
- Subjective Cognitive Decline (SCD)
- Mild Behavioral Impairment
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 60 to 89 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Stanford University
- Last updated on ClinicalTrials.gov
- April 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Stanford University CogT Lab · Palo Alto, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.